Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Our Businesses
Explore more Johnson & Johnson sites:

Johnson & Johnson Names Six Winners of First Women in STEM2D Scholars Award

Award is Part of Company’s Commitment to Support Women in Science, Technology, Engineering, Math, Manufacturing and Design (STEM2D).
Today's Top Reads Close

12 April 2018 – Johnson & Johnson (NYSE:JNJ) today named six inaugural winners of the Johnson & Johnson Women in STEM2D (WiSTEM2D) Scholars Award, which supports women at significant points in their research careers in the disciplines of Science, Technology, Engineering, Math, Manufacturing and Design (STEM2D). The women each will receive up to $150,000 in funding and three years of mentorship from Johnson & Johnson leaders as well as members of the Award’s Advisory Board.

The Award, which received more than 500 applicant submissions from women at universities and research facilities across the globe, is part of Johnson & Johnson’s ongoing commitment to harness the power of diversity to improve the health and well-being of people around the world. Johnson & Johnson launched the Award in June 2017 as part of its efforts to fuel the development of female STEM2D leaders and feed the worldwide STEM2D talent pipeline.

“The six women honored as recipients of the 2018 Johnson & Johnson WiSTEM2D Scholar Award represent the caliber of talent that we believe is essential to global innovation today and in future. The Award program, and its distinguished Advisory Board, are part of our company’s commitment to help increase the participation of women in STEM2D fields worldwide,” said Kathy Wengel, Worldwide Vice President and Chief Supply Chain Officer, Johnson & Johnson Supply Chain and WiSTEM2D Program Executive Sponsor.


The 2018 Johnson & Johnson WiSTEM2D Scholars Award solicited applications in 2017 from women pursuing careers in six STEM2D disciplines. The winners, representing each of the STEM2D disciplines, are:

  • SCIENCE: Seemay Chou, Ph.D., Assistant Professor in Biochemistry and Biophysics at University of California San Francisco – Identify Key Molecular Interactions that Underlie I. scapularis Vector Competence for B. burgdorferi.
  • TECHNOLOGY: Soojung Claire Hur, Ph.D., Clare Boothe Luce Assistant Professor of Mechanical Engineering at Johns Hopkins University – Development of a Microfluidic Electroporator for Genomic Engineering
  • ENGINEERING: Lauren Stadler, Ph.D., Assistant Professor in Civil and Environmental Engineering at Rice University – Research Networks and Rates of Antibiotic Resistance Gene Propagation in Water Treatment Systems
  • MANUFACTURING: Jennifer Pazour, Ph.D., Assistant Professor of Industrial and Systems Engineering at Rensselaer Polytechnic Institute – Evaluation of New Distribution Technologies via Novel Data-Driven Models
  • MATH: Jingyi Jessica Li, Ph.D., Assistant Professor of Statistics at University of California Los Angeles – Statistical Modeling to Quantitate the Central Dogma
  • DESIGN: Jessica Menold, Ph.D., Assistant Professor of Engineering Design and Mechanical Engineering at Pennsylvania State University – Increasing Product Success Through Effective Prototyping


An independent Advisory Board, comprised of five female leaders in a cross-section of the STEM2D disciplines, selected the inaugural winners of the WiSTEM2D Scholars Award. The board members are:

  • Mary Beckerle, Ph.D., CEO and Director of Huntsman Cancer Institute at the University of Utah [Chair]
  • Mary C. Boyce, Ph.D., Dean of Engineering, The Fu Foundation School of Engineering and Applied Science at Columbia University
  • Lei Lei, Ph.D., Professor and Dean of Rutgers Business School at Rutgers University
  • Dusa McDuff, Ph.D., Kimmel Professor of Mathematics at Barnard College, Columbia University
  • Juliana Rotich, Co-founder and Director, BRCK Inc.


Building a diverse STEM2D community is one approach Johnson & Johnson is taking as part of a broader effort to accelerate the development of women leaders and support women at all stages of their life to improve global health and well-being and drive sustainable economic growth. Johnson & Johnson launched the WiSTEM2D (Women in Science, Technology, Math, Manufacturing and Design) program in 2015 to increase the representation of women in science and technical fields. The program’s multifaceted approach is designed to engage females at three pivotal development stages in their lives:

  • Youth Programs (Ages 5 to 18 years): Johnson & Johnson is partnering with organizations to align curriculum in schools, augment program-based learning and engage Johnson & Johnson employees around the world as mentors to students.
  • University Talent: Johnson & Johnson is partnering with leading academic institutions to develop high-impact strategies for increasing the number of women enrolling in and graduating with STEM2D programs and degrees. At the graduate level, Johnson & Johnson has implemented to STEM2D Scholars Award to increase the number of women pursuing research in STEM2D fields.
  • Professionals: Johnson & Johnson is identifying and implementing best practices for attracting and retaining the world’s best technical female talent.

For more information visit:

About Johnson & Johnson
At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.

Sarah Rodriguez
+1 848 202 0249

Chelsea Hewitt
+1 415 405 6385

More from Johnson & Johnson

Back to top
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.